Strategic Pivot From Digital Promotion To Scientific Rigor
In Guangzhou, the vibrant manufacturing hub of China's beauty industry, Yatsen Holding unveiled a revised strategic blueprint that marks a fundamental evolution in corporate philosophy. Following a hyper-growth trajectory driven by viral social media campaigns and global acquisitions of prestigious labels like Galénic and Eve Lom, executive leadership has chosen to temper its transactional acquisition pace. Instead, the company is reallocating capital toward expanding its clinical skincare footprint and bolstering proprietary laboratory infrastructure, recognizing rigorous science as the only viable anchor for long-term brand equity.
Founder and CEO David Huang emphasized that the organization remains steadfast in committing 3 to 4 percent of annual top-line revenue toward scientific research, mirroring standards established by legacy global beauty conglomerates. This resource allocation departs from cost-undercutting tactics, building proprietary patent moats and specialized biochemical formulations designed to protect skin wellness.
"We firmly believe that our existing portfolio holds tremendous untapped potential, and this is the right moment to nurture that internal capability." CEO David Huang

















